Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
AstraZeneca
Harvard Business School
Colorcon
Boehringer Ingelheim
Healthtrust
Accenture
Chubb

Generated: September 26, 2018

DrugPatentWatch Database Preview

CEFACLOR Drug Profile

« Back to Dashboard

Drug patent expirations by year for CEFACLOR
Pharmacology for CEFACLOR
Medical Subject Heading (MeSH) Categories for CEFACLOR
Synonyms for CEFACLOR
(6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-((R)-2-amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2R)-2-amino-2-phenylacetamido]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(R)-2-AMINO-2-PHENYLACETAMIDO]-3-CHLORO-8-OXO-5-THIA-1-AZABICYCLO[4,2,0]OCT-2-ENE-2-CARBOXYLIC ACID
(6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid
3Z6FS3IK0K
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6-alpha,7-beta(R*)))-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-, (6R,7R)-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-, (6R,7R)-
53994-73-3
7-((2R)-2-amino-2-phenylacetylamino)(7R,7aR)-3-chloro-6-oxo-2H,7H-azetidino[2, 1-b]1,3-thiazine-4-carboxylic acid
7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid
AB00052174
AB00052174_15
AB00052174_16
ABP000537
AC1L1ABP
AJ-90585
AK162835
AKOS024282614
Alenfral
Alenfral (TN)
Alfacet
Alfatil
BCP9000501
BCPP000294
BDBM42131
BPBio1_000385
BPBio1_001326
BRD-K20338176-002-03-5
BSPBio_000349
BSPBio_001204
BSPBio_003276
C06877
CAS-53994-73-3
CCG-40264
CCL
Ceclor
Ceclor (TN)
Ceclor CD
Ceclor, Distaclor, Keflor, Raniclor, Cefaclor
Cefaclor (Ceclor)
Cefaclor (JP15)
Cefaclor (JP17)
Cefaclor (USP)
Cefaclor [INN]
Cefaclor [USAN:INN:BAN:JAN]
Cefaclor anhydrous
Cefaclor hydrate
Cefaclor, analytical reference material
Cefaclor, Antibiotic for Culture Media Use Only
Cefaclor(Ceclor)/
Cefacloro
Cefaclorum
Cefaclorum [INN-Latin]
Cefeaclor
Cephaclor
CHEBI:3478
cid_51039
CPD000058250
CS-2134
CTK1H0061
D00256
D0PW7C
DB00833
Distaclor
Distaclor (TN)
DivK1c_007043
DR002000
DSSTox_CID_2748
DSSTox_GSID_22748
DSSTox_RID_76713
DTXSID3022748
Dystaclor MR
EINECS 258-909-5
Epitope ID:117133
FT-0603069
HE350211
HMS1571M06
HMS1921G22
HMS2052C11
HMS2092K08
HMS2233M13
HY-B0198
KBio1_001987
KBio2_001550
KBio2_004118
KBio2_006686
KBio3_002777
KBioGR_000386
KBioSS_001550
Keflor
Keflor (TN)
Kefral
L-Kefral
Lilly 99638
losefar
MFCD00151471
MLS000069617
MLS001424193
MolPort-003-666-328
NC00354
NCGC00022612-04
NCGC00022612-05
NCGC00022612-06
NCGC00022612-07
NCGC00022612-10
NCGC00022612-11
NSC-757422
NSC757422
Panacef
Panoral
Pharmakon1600-01500771
Prestwick0_000485
Prestwick0_001102
Prestwick1_000485
Prestwick1_001102
Prestwick2_000485
Prestwick2_001102
Prestwick3_000485
Prestwick3_001102
QYIYFLOTGYLRGG-GPCCPHFNSA-N
Raniclor
Raniclor (TN)
S 6472
S-6472
SAM001246884
SBI-0051606.P002
SCHEMBL33540
SMR000058250
SPBio_001237
SPBio_002270
SPBio_003082
SpecPlus_000947
Spectrum_001070
SPECTRUM1500771
Spectrum2_001189
Spectrum3_001858
Spectrum4_000093
Spectrum5_001727
SR-05000001556
SR-05000001556-1
ST057228
ST24046293
Tox21_110880
Tox21_110880_1
UNII-3Z6FS3IK0K
ZINC3812869

US Patents and Regulatory Information for CEFACLOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Yung Shin Pharm CEFACLOR cefaclor FOR SUSPENSION;ORAL 065412-003 Feb 17, 2012 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ranbaxy CEFACLOR cefaclor FOR SUSPENSION;ORAL 064165-001 Oct 2, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
World Gen CEFACLOR cefaclor TABLET, EXTENDED RELEASE;ORAL 065057-001 Jan 5, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms CEFACLOR cefaclor FOR SUSPENSION;ORAL 064086-001 Apr 28, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
AstraZeneca
Harvard Business School
Colorcon
Boehringer Ingelheim
Healthtrust
Accenture
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.